Form EFFECT Tvardi Therapeutics,

May 14, 2026 6:08 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 13, 2026
Accession Number: 0001104659-26-057914
Submission Type: POS AM
CIK: 0001346830
Company Name: Tvardi Therapeutics, Inc.
File Number: 333-287675


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings